品牌：源叶(MedMol)

产品编号：Y31467 一键复制产品信息

CAS号：223132-37-4

分子式：C₂₇H₂₆N₄O₄S

分子量：502.58

别名：5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑啉二酮;伊诺他酮;inolitazone;5-[[4-[[6-(4-Amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]-2,4-thiazolidinedione;Ef

货号	规格	价格	上海	北京	珠海	重庆	武汉	购买数量
Y31467-5mg	≥98%	￥2510.00 Y31467-5mg ￥2510.00 3-5天	0 货期：3-5天	-	-	-	-
Y31467-25mg	≥98%	￥9300.00 Y31467-25mg ￥9300.00 3-5天	0 货期：3-5天	-	-	-	-

大包装询价收藏产品

加入购物车

到货通知，提交手机号入库后将短信通知。

体内研究：

Inolitazone (RS5444) plus Paclitaxel demonstrate additive antiproliferative activity in cell culture and minimal ATC tumor growth. When Inolitazone is administered in the diet to athymic nude mice prior to DRO tumor cell implantation, tumor growth is inhibited in a dose responsive fashion. At the highest dose, 0.025% Inolitazone inhibits growth on day 32 by 94.4% as compared to that of control. In this treatment group, five of 10 animals do not develop demonstrable tumors. In the 0.0025% treatment group, tumor growth is inhibited by 62.3% compared to that of control on day 32 while the 0.00025% dose demonstrated no growth inhibitory activity as compared to control. Tumors is nest allowed to establish in the mouse and began 0.025% Inolitazone treatment of mice 1 week after DRO or ARO tumor cell implantation. Inolitazone treated animals demonstrate tumor growth inhibition of 68.9% in DRO tumors and 48.3% in ARO tumors as compared to that of their respective controls on day 35.

保存条件：

-20℃

配置溶液浓度参考：

	1mg	5mg	10mg
1 mM	1.99 ml	9.949 ml	19.897 ml
5 mM	0.398 ml	1.99 ml	3.979 ml
10 mM	0.199 ml	0.995 ml	1.99 ml
50 mM	0.04 ml	0.199 ml	0.398 ml

注意：

部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

参考文献

质检证书(COA)

输入产品批号：

如何获取质检证书(COA)?

请输入货号和一个与之匹配的批号。
例如:
批号：JS298415 货号：S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

质量

浓度

体积

分子摩尔量

计算重置